Nice

News

A NICE yes for latest immunotherapy Bavencio

NICE has recommended Merck KGaA and Pfizer’s Bavencio in previously treated metastatic Merkel Cell Carcinoma, a rare and aggressive form of skin cancer.

Views & Analysis

A line of UK One Pound Coins on top of UK Banknotes (?5, ?10, ?20)

'Free' pricing in the UK: the influence of NICE and NHS Engl...

UK drug pricing: just how free is free pricing, these days?

News

NHS drug deal could fund vital cystic fibrosis research - Ve...

Vertex wants long-term funding for CF research

Views & Analysis

Four new rare disease treatments awaiting NICE review

Following yesterday’s international Rare Disease Day, here is a snapshot of four new rare disease treatments currently under review by England’s cost-effectiveness watchdog.

News